BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//132.216.98.100//NONSGML kigkonsult.se iCalcreator 2.20.4//
BEGIN:VEVENT
UID:20250927T213139EDT-9847aLC80U@132.216.98.100
DTSTAMP:20250928T013139Z
DESCRIPTION:October 4\, 2021\n	12:30 - 1:30 PM\n\nSEVENTH ANNUAL JGH DEPARTM
 ENT OF MEDICINE CLINICAL RESEARCH SYMPOSIUM\n\nI. DE-LABELING ANTIBIOTIC A
 LLERGY WITHOUT SKIN TESTING: AN UPDATE\n	\n	Jesse Schwartz\, MD\n	Assistant P
 rofessor of Medicine\, 91Ö±²¥\n	Division of Allergy and Immunolo
 gy\, Jewish General Hospital\n	\n	Educational Objectives:\n	1. Understand the
  risks and benefits of re-trying a medication after a patient has had an a
 dverse reaction\, with a focus on penicillin allergy\n	2. Provide an overvi
 ew of the DAAST study: De-labeling Antibiotic Allergy without Skin Testin
 \n\nII. PATIENT-LED REFERRAL FOR FAMILY MEMBERS AT THE TIME OF CARDIAC ICU
  ADMISSION\n	\n	Michael Goldfarb\, MD\, MSc\n	Assistant Professor of Medicine
 \, 91Ö±²¥\n	Division of Cardiology\, Jewish General Hospital\n	\n
 	Educational Objectives: \n	1. To describe a patient-initiated referral prog
 ram for family and household members at the time of a patient’s hospitaliz
 ation for acute coronary artery disease\n	2. To understand how a family-ori
 ented approach to primary cardiovascular prevention in family and househol
 d members can identify and improve cardiovascular\n\nIII. ONGOING TRIALS I
 N THE JGH DIALYSIS UNITS\n	\n	Daniel Blum\, MD\n	Assistant Professor of Medic
 ine\, 91Ö±²¥\n	Division of Nephrology\, Jewish General Hospital
 \n	\n	Educational Objectives: \n	1. Review the equipoise around anticoagulati
 on for stroke prophylaxis for atrial fibrillation among people receiving d
 ialysis: SAFE-D Trial\n	2. Review the equipoise around targeting low serum 
 phosphate to improve cardiovascular outcomes among people receiving dialys
 is: PHOSPHATE Trial\n	\n	Contact Person: Vicky Tagalakis\, MD\, MSc\, Divisi
 on of Internal Medicine\, Tel. 514-340-7596.\n\n**\n	\n	October 11\, 2021\n
 \nNo Rounds - Thanksgiving\n\n**\n	\n	October 18\, 2021\n	12:30 - 1:30 PM\n\n
 A TRANSLATIONAL APPROACH TO BASAL CELL CARCINOMA \n	\n	Philippe Lefrançois\,
  MD\, PhD \n	Assistant Professor of Medicine\, 91Ö±²¥\n	Division 
 of Dermatology\, Jewish General Hospital\n	Investigator\, Lady Davis Instit
 ute for Medical Research\n	\n	Educational Objectives: \n	1. Understand the ep
 idemiology\, clinical features and dermoscopic features of basal cell carc
 inoma (BCC)\n	2. Explore the broad therapeutic modalities for BCC according
  to clinically-relevant features\n	3. Learn novel signalling pathways and a
 ctionable targets for BCC from cancer genomics\n	\n	Contact Person: Robin Bi
 llick\, MD\, Chief\, Division of Dermatology\, Tel. 514-340-8222 ext. 2506
 5.\n\n**\n\nOctober 25\, 2021\n	12:30 - 1:30 PM\n	\n	UPDATE ON DELIRIUM AND T
 HE HOSPITAL ELDER LIFE PROGRAM (HELP) \n	\n	Fred H. Rubin\, MD\n	Professor of
  Medicine\, Division of Geriatric Medicine\n	University of Pittsburgh Schoo
 l of Medicine\n	\n	Educational Objectives:\n	1. Understand the criteria for d
 iagnosis of delirium and how to apply them in a clinical situation.\n	2. Re
 cognize the harms that delirium can cause\n	3. Appreciate that nearly half 
 of all cases of delirium can be prevented\n	\n	Contact Person: José Morais\,
  MD\, Chief\, Division of Geriatric Medicine\, Tel. 514-340-7501.\n\n\n	Cli
 ck here for more info and the Microsoft Teams link.\n\n \n
DTSTART;VALUE=DATE:20211004
DTEND;VALUE=DATE:20211025
SUMMARY:JGH Virtual Medical Grand Rounds - October 2021
URL:/medhealthsci/channels/event/jgh-virtual-medical-g
 rand-rounds-october-2021-333843
END:VEVENT
END:VCALENDAR